Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer
详细信息 查看全文
- 作者：Niccolo Passoni ; M.D.a ; niccolo.passoni@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Bishoy Gayed ; M.D.a ; b ; Payal Kapur ; M.D.c ; Arthur I. Sagalowsky ; M.D.a ; Shahrokh F. Shariat ; M.D.a ; d ; Yair Lotan ; M.D.a
- 关键词：Non&ndash ; muscle-invasive bladder cancer ; High-risk ; Markers ; Risk tables ; Outcomes
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：34
- 期：11
- 页码：485.e7-485.e14
- 全文大小：306 K
文摘
- •
Patients with high-grade non–muscle-invasive bladder cancer are a heterogeneous population.
- •
Statistical models, such as the EORTC and CUETO ones, were developed to improve outcomes prediction.
- •
Cell-cycle markers have been associated with outcomes after radical cystectomy.
- •
Unfortunately these markers do not improve prediction at the time of TURBT.